Manufacturer
Novartis NDC Codes
Finished products listed with the FDA under labeler names that contain “Novartis”.
Products
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Pluvictolutetium lu 177 vipivotide tetraxetan | Lutetium lu-177 vipivotide tetraxetan 27 mCi/mL | Injection, SolutionIntravenous | Novartis Pharmaceuticals Corporation | 0078-1217 |
| Promactaeltrombopag olamine | Eltrombopag olamine 12.5 mg/1 | Tablet, Film coatedOral | Novartis Pharmaceuticals Corporation | 0078-0684 |
| Promactaeltrombopag olamine | Eltrombopag olamine 25 mg/1 | Tablet, Film coatedOral | Novartis Pharmaceuticals Corporation | 0078-0685 |
| Promactaeltrombopag olamine | Eltrombopag olamine 50 mg/1 | Tablet, Film coatedOral | Novartis Pharmaceuticals Corporation | 0078-0686 |
| Promactaeltrombopag olamine | Eltrombopag olamine 75 mg/1 | Tablet, Film coatedOral | Novartis Pharmaceuticals Corporation | 0078-0687 |
| Promactaeltrombopag olamine | Eltrombopag olamine 25 mg/1 | Powder, For suspensionOral | Novartis Pharmaceuticals Corporation | 0078-0697 |
| Promactaeltrombopag olamine | Eltrombopag olamine 12.5 mg/1 | Powder, For suspensionOral | Novartis Pharmaceuticals Corporation | 0078-0972 |
| Rhapsidoremibrutinib | Remibrutinib 25 mg/1 | TabletOral | Novartis Pharmaceuticals Corporation | 0078-1483 |
| Ritalin LAmethylphenidate hydrochloride | Methylphenidate hydrochloride 20 mg/1 | Capsule, Extended releaseOral | Novartis Pharmaceuticals Corporation | 0078-0370 |
| Ritalin LAmethylphenidate hydrochloride | Methylphenidate hydrochloride 30 mg/1 | Capsule, Extended releaseOral | Novartis Pharmaceuticals Corporation | 0078-0371 |
| Ritalin LAmethylphenidate hydrochloride | Methylphenidate hydrochloride 40 mg/1 | Capsule, Extended releaseOral | Novartis Pharmaceuticals Corporation | 0078-0372 |
| Ritalin LAmethylphenidate hydrochloride | Methylphenidate hydrochloride 10 mg/1 | Capsule, Extended releaseOral | Novartis Pharmaceuticals Corporation | 0078-0424 |
| Rydapt | Midostaurin 25 mg/1 | Capsule, Liquid filledOral | Novartis Pharmaceuticals Corporation | 0078-0698 |
| Sandimmunecyclosporine | Cyclosporine 50 mg/mL | InjectionIntravenous | Novartis Pharmaceuticals Corporation | 0078-0109 |
| Sandimmunecyclosporine | Cyclosporine 25 mg/1 | Capsule, Liquid filledOral | Novartis Pharmaceuticals Corporation | 0078-0240 |
| Sandimmunecyclosporine | Cyclosporine 100 mg/1 | Capsule, Liquid filledOral | Novartis Pharmaceuticals Corporation | 0078-0241 |
| Sandostatinoctreotide acetate | Octreotide acetate 50 ug/mL | Injection, SolutionIntravenous, Subcutaneous | Novartis Pharmaceuticals Corporation | 0078-0180 |
| Sandostatinoctreotide acetate | Octreotide acetate 100 ug/mL | Injection, SolutionIntravenous, Subcutaneous | Novartis Pharmaceuticals Corporation | 0078-0181 |
| Sandostatinoctreotide acetate | Octreotide acetate 500 ug/mL | Injection, SolutionIntravenous, Subcutaneous | Novartis Pharmaceuticals Corporation | 0078-0182 |
| Sandostatin LAR Depotoctreotide acetate | — | Kit | Novartis Pharmaceuticals Corporation | 0078-0811 |
| Sandostatin LAR Depotoctreotide acetate | — | Kit | Novartis Pharmaceuticals Corporation | 0078-0818 |
| Sandostatin LAR Depotoctreotide acetate | — | Kit | Novartis Pharmaceuticals Corporation | 0078-0825 |
| Scemblixasciminib | Asciminib hydrochloride 20 mg/1 | Tablet, Film coatedOral | Novartis Pharmaceuticals Corporation | 0078-1091 |
| Scemblixasciminib | Asciminib hydrochloride 40 mg/1 | Tablet, Film coatedOral | Novartis Pharmaceuticals Corporation | 0078-1098 |
| Scemblixasciminib | Asciminib hydrochloride 100 mg/1 | Tablet, Film coatedOral | Novartis Pharmaceuticals Corporation | 0078-1196 |